| |
| |
|
| Insider
Information: |
Mullen James C |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
227,563 |
|
|
Indirect Shares
|
75,000 |
|
|
| Direct
Value |
$29,809,992 |
|
|
|
Indirect Value
|
$16,870,500 |
|
|
| Total
Shares |
302,563 |
|
|
| Total
Value |
$46,680,492 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-2.0
|
| Percentage
Gain/Loss : |
 -18.6%
|
-115.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
CEO & President, Direc... |
2010-06-08 |
95,503 |
2010-06-08 |
75,000 |
Premium* |
|
|
Perkinelmer Inc |
PKI |
Director |
2014-11-14 |
45,551 |
2004-04-27 |
0 |
Premium* |
|
|
Patheon NV |
PTHN |
Chief Executive Office... |
2017-08-29 |
0 |
2017-08-29 |
0 |
Premium* |
|
|
Insulet Corp |
PODD |
Director |
2018-05-16 |
7,783 |
2017-08-09 |
0 |
Premium* |
|
|
Editas Medicine, Inc. |
EDIT |
CEO, Director |
2022-01-03 |
75,898 |
2018-05-18 |
0 |
Premium* |
|
|
Thermo Fisher Scientific |
TMO |
Director |
2024-05-22 |
2,828 |
2019-05-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTHN |
Patheon NV |
CEO |
• • – |
2017-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
93,432 |
1,000,290 |
0 |
- |
|
| PTHN |
Patheon NV |
Chief Executive Officer |
• • – |
2016-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
906,858 |
906,858 |
0 |
- |
|
| PTHN |
Patheon NV |
Chief Executive Officer |
• • – |
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(93,432) |
906,858 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-04-11 |
4 |
OE |
$37.45 |
$30,751,255 |
D/D |
745,750 |
882,250 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-04-11 |
4 |
AS |
$64.04 |
$4,747,643 |
D/D |
(73,927) |
808,323 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-04-11 |
4 |
AS |
$64.30 |
$7,800,280 |
D/D |
(121,157) |
687,166 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-04-11 |
4 |
AS |
$64.46 |
$6,586,855 |
D/D |
(102,019) |
585,147 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2010-03-19 |
4 |
OE |
$49.03 |
$17,197,606 |
D/D |
334,221 |
465,370 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-04-11 |
4 |
AS |
$64.71 |
$12,664,864 |
D/D |
(195,162) |
389,985 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2006-11-16 |
4 |
OE |
$35.42 |
$8,250,031 |
D/D |
229,877 |
255,129 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2006-11-20 |
4 |
OE |
$36.09 |
$5,738,310 |
D/D |
159,000 |
253,252 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
59,300 |
241,208 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2010-03-22 |
4 |
OE |
$49.03 |
$5,210,859 |
D/D |
106,279 |
237,428 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2007-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
170,000 |
216,458 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,667 |
201,375 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-04-11 |
4 |
AS |
$64.96 |
$12,829,104 |
D/D |
(197,315) |
192,670 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-02-07 |
4 |
D |
$61.58 |
$598,866 |
D/D |
(9,725) |
191,650 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2009-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
49,455 |
185,398 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-02-13 |
4 |
D |
$63.24 |
$616,084 |
D/D |
(9,742) |
181,908 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2007-02-13 |
4 |
D |
$49.17 |
$2,052,848 |
D/D |
(41,750) |
174,708 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2006-11-17 |
4 |
OE |
$36.09 |
$2,530,739 |
D/D |
70,123 |
164,375 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2009-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,666 |
163,166 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2009-02-07 |
4 |
D |
$52.48 |
$484,285 |
D/D |
(9,228) |
153,938 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-04-15 |
4 |
OE |
$44.59 |
$570,752 |
D/D |
12,800 |
149,300 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
48,961 |
144,847 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
